Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (21418)	5/26/1998 10:37:00 PM
From: Peter Singleton	Read Replies (1) \| Respond to of 32384

Mudcat Bob, Today's LGND action was just market sour, and sour on biotechs, IMO. No reason, I'd think, to suspect the NDA is delayed. LGND has been clear about the May filing date, and recently. There's nothing significant that could have come up in the past few weeks ... it's just packaging and shipping now, though those are no mean beasts for a task this big. I don't expect the stock to react much to the NDA, though I'm probably not the best at predicting the market's reaction to stuff like this. ODAC Ontak review is significant, though, and I would expect the market to react either way. How much, is anybody's guess, but a favorable review would have a material effect on LGND's near-term value. Peter